Rubén Cuttica
Hospital Pedro de Elizalde(AR)
Publications by Year
Research Areas
Autoimmune and Inflammatory Disorders Research, Adolescent and Pediatric Healthcare, Rheumatoid Arthritis Research and Therapies, Acute Lymphoblastic Leukemia research, Inflammatory Myopathies and Dermatomyositis
Most-Cited Works
- → Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis(2012)855 cited
- → Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus(2018)524 cited
- → A randomized, placebo‐controlled trial of infliximab plus methotrexate for the treatment of polyarticular‐course juvenile rheumatoid arthritis(2007)408 cited
- → Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial(2014)306 cited
- → Long‐term outcome and prognostic factors of juvenile dermatomyositis: A multinational, multicenter study of 490 patients(2009)277 cited
- → Systemic sclerosis in childhood: Clinical and immunologic features of 153 patients in an international database(2006)230 cited
- → Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial(2015)224 cited
- → The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis(2007)214 cited
- → Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study(2019)203 cited
- → 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis(2017)144 cited